Medspa Software Comparison: Boulevard vs Aesthetic Record vs PatientNow vs Symplast

Boulevard is a pure cloud platform built from the ground up for SaaS delivery. All data lives in the cloud; there is no on-premise option. This means automatic updates, no server maintenance, and uniform feature rollout across all users. The trade-off is zero control over deployment timing and full dependence on Boulevard's infrastructure and uptime.

Aesthetic Record and PatientNow offer hybrid models: cloud-based core with optional local caching or hybrid sync. This flexibility appeals to practices that want redundancy or have legacy integrations requiring local data presence. Symplast is primarily cloud but maintains tighter integration with certain device manufacturers (notably InMode and Cutera), which can mean proprietary data flows.

Practical implication: If your practice runs on a single location with reliable internet, cloud-native (Boulevard) is simpler. If you have multiple locations, poor connectivity, or need offline charting capability, hybrid (Aesthetic Record, PatientNow) may be worth the added complexity. Symplast's device integration is valuable only if you use its partner hardware; otherwise it's a neutral factor.

Boulevard charges per provider (typically $200–$400/month per injector or clinician) plus a base platform fee. This scales linearly with headcount and incentivizes lean staffing models. High-volume practices with many injectors see costs climb quickly.

Aesthetic Record and PatientNow typically use per-location or tiered pricing: a base fee ($500–$1,500/month) covers unlimited users at that location, with add-ons for additional locations or modules. This favors multi-provider practices and makes staffing additions cheaper after the base is paid.

Symplast uses a hybrid: base fee plus per-provider charges, but often bundles device integration and marketing tools, which can offset the per-user cost if you use those features.

Practical implication: Calculate your all-in cost for your actual staffing model. A solo injector might pay $300/month on Boulevard but $800/month on Aesthetic Record (base fee). A practice with six injectors might pay $1,800 on Boulevard but $1,200 on Aesthetic Record. Request pricing for your exact scenario; marketing quotes often omit per-user overages.

Boulevard's charting is consumer-friendly and mobile-optimized, designed for speed during appointments. It includes HIPAA compliance and basic before/after photo management. However, it offers limited customization for complex treatment protocols or multi-step procedures.

Aesthetic Record and PatientNow both offer more granular clinical charting: customizable templates, detailed injection mapping, product lot tracking, and adverse-event logging. PatientNow integrates tightly with inventory management and can flag expired products or low stock during charting. Aesthetic Record emphasizes compliance documentation and is popular in practices with regulatory scrutiny or high-volume toxin/filler use.

Symplast's charting is device-centric: it auto-populates treatment parameters from connected devices (RF depth, energy, pulse duration) and links them to patient outcomes. This is powerful for practices doing high-volume energy-device work but less useful if your revenue is primarily injectables.

Practical implication: If you do mostly injectables, Aesthetic Record or PatientNow's inventory and lot-tracking features will save you time and reduce compliance risk. If you do high-volume laser/RF, Symplast's device integration may justify its cost. Boulevard is adequate for simple practices but will feel limiting as you scale or add modalities.

Boulevard includes a robust patient portal with appointment booking, payment processing, and pre-visit questionnaires. It also offers built-in SMS and email marketing, which is valuable for retention and upsell. The portal is polished and drives patient engagement; many practices report higher no-show reduction and booking velocity after switching to Boulevard.

Aesthetic Record and PatientNow offer patient portals but with less marketing automation. Both integrate with third-party email/SMS platforms (Klaviyo, Mailchimp) and require additional setup. PatientNow's portal is more clinical (treatment history, consent forms) than consumer-facing.

Symplast includes a patient app with before/after galleries and treatment tracking, plus integration with marketing platforms. It also offers loyalty-program management, which is useful if you run a rebate or points system.

Practical implication: If patient acquisition and retention marketing are core to your growth strategy, Boulevard's integrated tools save you the cost and friction of third-party platforms. If you already have a marketing stack or prefer to outsource that function, the other platforms' flexibility is an advantage, not a limitation.

Boulevard integrates with major payment processors (Stripe, Square), accounting software (QuickBooks, Xero), and some device APIs. Its integration library is growing but remains smaller than competitors. Custom integrations require developer work and are not always supported.

Aesthetic Record and PatientNow have broader integration ecosystems: they connect to Allergan's Alle loyalty program, Galderma's Aspire program, Evolus Rewards, and major EHR systems. PatientNow's API is more open, making custom integrations easier. Both integrate with accounting, payroll, and CRM platforms.

Symplast's strength is device integration: it has native connectors to InMode, Cutera, Lumenis, and other manufacturers. If you use those devices, data flows automatically. It also integrates with Alle and Aspire.

Practical implication: Before choosing, audit your existing tools and planned integrations. If you rely on Alle rebates or Aspire loyalty, Aesthetic Record or PatientNow will integrate natively. If you use InMode or Cutera devices, Symplast saves integration work. Boulevard's smaller ecosystem means more manual data entry or custom development if you have complex needs.

Boulevard offers phone and email support during business hours, with a responsive community forum. Training is self-service (video library) or paid onboarding. Switching away from Boulevard is relatively frictionless: data exports are available, and the platform has no long-term lock-in contracts (though month-to-month pricing can add up).

Aesthetic Record and PatientNow both offer dedicated onboarding and training, often including in-person setup for larger practices. Support is more personalized. Both have longer implementation timelines (4–8 weeks vs. Boulevard's 1–2 weeks) but result in deeper customization. Switching costs are higher because of customization and data complexity.

Symplast offers white-glove onboarding and device integration support. Its support team is smaller but highly specialized. Switching away requires device re-integration elsewhere, which can be time-consuming.

Practical implication: If you want fast deployment and minimal hand-holding, Boulevard is fastest. If you need customization and ongoing support, Aesthetic Record or PatientNow justify the longer setup. Symplast is best if you need device integration expertise. Factor in switching costs: a practice that outgrows Boulevard in 18 months and migrates to Aesthetic Record will lose 2–4 weeks of productivity and staff retraining.